Statistics
Publications
51
Citations
2.1K
H-Index
26
Active since
2005
Feifei Xu is an author at Nanjing Medical University specializing in oncology, molecular oncology, and life sciences.
Publications per year
2005–2025
51
51
cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity
Zining Wang, Jiemin Chen, Jie Hu et al. · Journal of Clinical Investigation · 2019 · 254 citations · Full text
Medicine, Oncology, Pharmacology +17
Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma
Lu Zhang, Xian-meng Li, Xu-he Shi et al. · Acta Pharmacologica Sinica · 2022 · 87 citations · Full text
Medicine, Oncology, Pharmacology +16
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
Feifei Xu, Fengliang Wang, Ting Yang et al. · Cancer Cell International · 2014 · 86 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 51